Issue 67, 2016, Issue in Progress

DOTMA-based amides (DOTMAMs) as a platform for the development of PARACEST MRI contrast agents

Abstract

A synthetic methodology leading to previously unknown DOTMA-based secondary amides (DOTMAMs) has been developed. Alkylation of cyclen with L-lactic acid-derived pseudohalides was used as a key step affording the alkyl- and aryl-decorated DOTMAMs. Amino acid-decorated DOTMAMs were obtained via peptide coupling between DOTMA and protected amino acids. Metallation of the DOTMAMs ligand with Tm3+ gave complexes exhibiting proximal amide proton based paramagnetic CEST effects at <−50 ppm relative to water.

Graphical abstract: DOTMA-based amides (DOTMAMs) as a platform for the development of PARACEST MRI contrast agents

Supplementary files

Article information

Article type
Paper
Submitted
05 May 2016
Accepted
21 Jun 2016
First published
24 Jun 2016

RSC Adv., 2016,6, 62647-62655

Author version available

DOTMA-based amides (DOTMAMs) as a platform for the development of PARACEST MRI contrast agents

M. Suchý, A. X. Li, M. Milne, R. Bartha and R. H. E. Hudson, RSC Adv., 2016, 6, 62647 DOI: 10.1039/C6RA11741D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements